Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
| 02/28/2017 | 11/30/2016 | 08/31/2016 | 05/31/2016 | 02/29/2016 | |
|---|---|---|---|---|---|
| Net Income | 97.36% | -2,595.00% | -21.81% | 26.87% | -104.71% |
| Total Depreciation and Amortization | 0.00% | 31.25% | -30.43% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.00% | -- | -- | -- | -- |
| Change in Net Operating Assets | -163.03% | 666.67% | 38.69% | -269.14% | 30.65% |
| Cash from Operations | -1.13% | -3.34% | -10.43% | -5.24% | -131.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -200.00% | -- | 100.00% | -3,965.98% | -97.42% |
| Total Debt Repaid | -- | -- | -- | 100.00% | -6,300.00% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -200.00% | -- | -- | -100.00% | -99.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.46% | -1.16% | -10.43% | -11.65% | -115.90% |